$FFR 4 SEC Filings

Filed On	Filing
04 Aug 2022	Form 4: Abdul-Ahad Wajdi, Vice President, R & D, CSO Granted 80,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Lotz Christopher L., Vice President of Finance, CFO Granted 100,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Arshad Tariq, SVP/Chief Medical Officer Granted 102,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Ritter Ira E., Director Granted 40,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Emery Sidney W Jr, Director Granted 40,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Kruger Kurt H, Director Granted 40,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: David Richard A., Director Granted 40,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Sinha Shishir K., VP, COO & Secretary Granted 100,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Poirier Michael S., Director Granted 375,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Korenberg Matthew E, Director Granted 40,000 Stock Option (Right to Buy)
04 Aug 2022	Form 4: Broidrick Amy S., Director Granted 130,000 Stock Option (Right to Buy)
22 Jun 2022	Form 4: Poirier Michael S., Director Bought 30,000 shares ($17.1K)
15 Jun 2022	Form 4: Broidrick Amy S., Director Bought 30,000 shares ($18.6K)
10 Dec 2021	Form 4: Broidrick Amy S., Director Granted 300,000 Stock Option (Right to Buy)
10 Dec 2021	Form 4: Arshad Tariq, SVP/Chief Medical Officer Granted 300,000 Stock Option (Right to Buy)
20 Aug 2021	Form 4: Kruger Kurt H, Director Bought 8,000 shares ($9.8K)
18 May 2021	Form 4: Arshad Tariq, SVP/Chief Medical Officer Granted 100,000 Stock Option (Right to Buy)
26 Apr 2021	Form 4: Broidrick Amy S., Director Bought 4,500 shares ($9.14K)
21 Apr 2021	Form 4: Poirier Michael S., Director Bought 11,005 shares ($19.8K)
19 Apr 2021	Form 4: Lotz Christopher L., Vice President of Finance, CFO Bought 2,700 shares ($5.02K)

Comments